Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Collagen-induced platelet aggregation blocker revacept - a possible role as a dialysate additive? |
|
|
| Circulation: Conclusion— This phase I study demonstrated that Revacept is a safe and well-tolerated new antiplatelet compound with a clear dose-dependent pharmacokinetic profile with specific, dose-related inhibition of platelet aggregation despite completely unaltered general hemostasis. |
Professional dialysis recruitment

